- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human monoclonal antibody binding to vascular ad
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human monoclonal antibody binding to vascular adhesion protein-1
| EU orphan designation number: | EU/3/15/1461
|
| Active ingredient: | Recombinant human monoclonal antibody binding to vascular adhesion protein-1 |
| Indication: | Treatment of primary sclerosing cholangitis |
| Sponsor: | Biotie Therapies Corp
Joukahaisenkatu 6, 20520 Turku, Suomi |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 23/03/2015 | Orphan designation | EMA/OD/288/14 | (2015)2030 of 19/03/2015 |
CONTACT
EU links
Directorate General Health & Consumers